SkinBioTherapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is July - June.

Millions EUR. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2019
Period Ending	Nov '25 Nov 26, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2016 - 2019
Market Capitalization	50	21	25	37	116	24	Upgrade
Market Cap Growth	17.14%	-16.68%	-31.73%	-68.18%	380.53%	-15.64%	Upgrade
Enterprise Value	50	18	24	33	110	21	Upgrade
Last Close Price	0.17	0.08	0.13	0.21	0.73	-	Upgrade
PS Ratio	15.45	14.72	163.89	424.66	-	-	Upgrade
PB Ratio	9.22	5.99	10.85	12.83	19.09	8.90	Upgrade
P/TBV Ratio	175.22	-	16.72	17.16	21.24	10.72	Upgrade
EV/Sales Ratio	16.34	12.45	158.92	384.18	-	-	Upgrade
Debt / Equity Ratio	0.23	0.28	0.05	0.05	0.03	-	Upgrade
Asset Turnover	0.47	0.31	0.05	0.02	-	-	Upgrade
Inventory Turnover	2.71	2.08	0.60	-	-	-	Upgrade
Quick Ratio	1.21	0.63	3.05	4.19	11.91	7.55	Upgrade
Current Ratio	1.79	0.93	3.25	4.58	12.50	7.70	Upgrade
Return on Equity (ROE)	-63.28%	-115.85%	-126.85%	-72.62%	-37.31%	-47.80%	Upgrade
Return on Assets (ROA)	-27.75%	-46.50%	-66.02%	-42.26%	-22.00%	-30.21%	Upgrade
Return on Capital (ROIC)	-34.47%	-61.71%	-79.79%	-46.84%	-23.93%	-32.27%	Upgrade
Return on Capital Employed (ROCE)	-43.60%	-85.20%	-145.30%	-115.80%	-28.10%	-65.70%	Upgrade
Earnings Yield	-6.22%	-16.16%	-13.10%	-8.80%	-1.44%	-6.84%	Upgrade
FCF Yield	-	-15.40%	-12.64%	-8.42%	-1.56%	-4.07%	Upgrade
Buyback Yield / Dilution	-19.79%	-13.10%	-5.06%	-6.87%	-14.53%	-4.95%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.